학술논문
No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta
Document Type
Artikel
Author
Source
Journal of hepatology. 79(3):657-665
Subject
Language
English
English
English
ISSN
1600-0641